Global Gene Therapy For Cancer Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 86

Published Date: 01 Jan 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Gene therapy refers to the introduction of foreign genes into target cells to correct or compensate for diseases caused by gene defects and/or abnormal gene expression.

According to our (Global Info Research) latest study, the global Gene Therapy For Cancer market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Gene Therapy For Cancer market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Gene Therapy For Cancer market size and forecasts, in consumption value ($ Million), 2018-2029
Global Gene Therapy For Cancer market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Gene Therapy For Cancer market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Gene Therapy For Cancer market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Gene Therapy For Cancer
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Gene Therapy For Cancer market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GLIEAD, REGENXBIO, Autolus, American Gene Technologies and Arcellx, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Gene Therapy For Cancer market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Rb Gene
    P53 Gene
    APC Gene
    NF1 Gene
    Others

Market segment by Application
    Cancer Treatment
    Tissue Repair
    Others

Market segment by players, this report covers
    GLIEAD
    REGENXBIO
    Autolus
    American Gene Technologies
    Arcellx
    AUSTRIANOVA
    Alphavax
    Cellectis
    Chimeron

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Gene Therapy For Cancer product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Gene Therapy For Cancer, with revenue, gross margin and global market share of Gene Therapy For Cancer from 2018 to 2023.
Chapter 3, the Gene Therapy For Cancer competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Gene Therapy For Cancer market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Gene Therapy For Cancer.
Chapter 13, to describe Gene Therapy For Cancer research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Gene Therapy For Cancer
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Gene Therapy For Cancer by Type
        1.3.1 Overview: Global Gene Therapy For Cancer Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Gene Therapy For Cancer Consumption Value Market Share by Type in 2022
        1.3.3 Rb Gene
        1.3.4 P53 Gene
        1.3.5 APC Gene
        1.3.6 NF1 Gene
        1.3.7 Others
    1.4 Global Gene Therapy For Cancer Market by Application
        1.4.1 Overview: Global Gene Therapy For Cancer Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Cancer Treatment
        1.4.3 Tissue Repair
        1.4.4 Others
    1.5 Global Gene Therapy For Cancer Market Size & Forecast
    1.6 Global Gene Therapy For Cancer Market Size and Forecast by Region
        1.6.1 Global Gene Therapy For Cancer Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Gene Therapy For Cancer Market Size by Region, (2018-2029)
        1.6.3 North America Gene Therapy For Cancer Market Size and Prospect (2018-2029)
        1.6.4 Europe Gene Therapy For Cancer Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Gene Therapy For Cancer Market Size and Prospect (2018-2029)
        1.6.6 South America Gene Therapy For Cancer Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Gene Therapy For Cancer Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 GLIEAD
        2.1.1 GLIEAD Details
        2.1.2 GLIEAD Major Business
        2.1.3 GLIEAD Gene Therapy For Cancer Product and Solutions
        2.1.4 GLIEAD Gene Therapy For Cancer Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 GLIEAD Recent Developments and Future Plans
    2.2 REGENXBIO
        2.2.1 REGENXBIO Details
        2.2.2 REGENXBIO Major Business
        2.2.3 REGENXBIO Gene Therapy For Cancer Product and Solutions
        2.2.4 REGENXBIO Gene Therapy For Cancer Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 REGENXBIO Recent Developments and Future Plans
    2.3 Autolus
        2.3.1 Autolus Details
        2.3.2 Autolus Major Business
        2.3.3 Autolus Gene Therapy For Cancer Product and Solutions
        2.3.4 Autolus Gene Therapy For Cancer Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Autolus Recent Developments and Future Plans
    2.4 American Gene Technologies
        2.4.1 American Gene Technologies Details
        2.4.2 American Gene Technologies Major Business
        2.4.3 American Gene Technologies Gene Therapy For Cancer Product and Solutions
        2.4.4 American Gene Technologies Gene Therapy For Cancer Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 American Gene Technologies Recent Developments and Future Plans
    2.5 Arcellx
        2.5.1 Arcellx Details
        2.5.2 Arcellx Major Business
        2.5.3 Arcellx Gene Therapy For Cancer Product and Solutions
        2.5.4 Arcellx Gene Therapy For Cancer Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Arcellx Recent Developments and Future Plans
    2.6 AUSTRIANOVA
        2.6.1 AUSTRIANOVA Details
        2.6.2 AUSTRIANOVA Major Business
        2.6.3 AUSTRIANOVA Gene Therapy For Cancer Product and Solutions
        2.6.4 AUSTRIANOVA Gene Therapy For Cancer Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 AUSTRIANOVA Recent Developments and Future Plans
    2.7 Alphavax
        2.7.1 Alphavax Details
        2.7.2 Alphavax Major Business
        2.7.3 Alphavax Gene Therapy For Cancer Product and Solutions
        2.7.4 Alphavax Gene Therapy For Cancer Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Alphavax Recent Developments and Future Plans
    2.8 Cellectis
        2.8.1 Cellectis Details
        2.8.2 Cellectis Major Business
        2.8.3 Cellectis Gene Therapy For Cancer Product and Solutions
        2.8.4 Cellectis Gene Therapy For Cancer Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Cellectis Recent Developments and Future Plans
    2.9 Chimeron
        2.9.1 Chimeron Details
        2.9.2 Chimeron Major Business
        2.9.3 Chimeron Gene Therapy For Cancer Product and Solutions
        2.9.4 Chimeron Gene Therapy For Cancer Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Chimeron Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Gene Therapy For Cancer Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Gene Therapy For Cancer by Company Revenue
        3.2.2 Top 3 Gene Therapy For Cancer Players Market Share in 2022
        3.2.3 Top 6 Gene Therapy For Cancer Players Market Share in 2022
    3.3 Gene Therapy For Cancer Market: Overall Company Footprint Analysis
        3.3.1 Gene Therapy For Cancer Market: Region Footprint
        3.3.2 Gene Therapy For Cancer Market: Company Product Type Footprint
        3.3.3 Gene Therapy For Cancer Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Gene Therapy For Cancer Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Gene Therapy For Cancer Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Gene Therapy For Cancer Consumption Value Market Share by Application (2018-2023)
    5.2 Global Gene Therapy For Cancer Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Gene Therapy For Cancer Consumption Value by Type (2018-2029)
    6.2 North America Gene Therapy For Cancer Consumption Value by Application (2018-2029)
    6.3 North America Gene Therapy For Cancer Market Size by Country
        6.3.1 North America Gene Therapy For Cancer Consumption Value by Country (2018-2029)
        6.3.2 United States Gene Therapy For Cancer Market Size and Forecast (2018-2029)
        6.3.3 Canada Gene Therapy For Cancer Market Size and Forecast (2018-2029)
        6.3.4 Mexico Gene Therapy For Cancer Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Gene Therapy For Cancer Consumption Value by Type (2018-2029)
    7.2 Europe Gene Therapy For Cancer Consumption Value by Application (2018-2029)
    7.3 Europe Gene Therapy For Cancer Market Size by Country
        7.3.1 Europe Gene Therapy For Cancer Consumption Value by Country (2018-2029)
        7.3.2 Germany Gene Therapy For Cancer Market Size and Forecast (2018-2029)
        7.3.3 France Gene Therapy For Cancer Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Gene Therapy For Cancer Market Size and Forecast (2018-2029)
        7.3.5 Russia Gene Therapy For Cancer Market Size and Forecast (2018-2029)
        7.3.6 Italy Gene Therapy For Cancer Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Gene Therapy For Cancer Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Gene Therapy For Cancer Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Gene Therapy For Cancer Market Size by Region
        8.3.1 Asia-Pacific Gene Therapy For Cancer Consumption Value by Region (2018-2029)
        8.3.2 China Gene Therapy For Cancer Market Size and Forecast (2018-2029)
        8.3.3 Japan Gene Therapy For Cancer Market Size and Forecast (2018-2029)
        8.3.4 South Korea Gene Therapy For Cancer Market Size and Forecast (2018-2029)
        8.3.5 India Gene Therapy For Cancer Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Gene Therapy For Cancer Market Size and Forecast (2018-2029)
        8.3.7 Australia Gene Therapy For Cancer Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Gene Therapy For Cancer Consumption Value by Type (2018-2029)
    9.2 South America Gene Therapy For Cancer Consumption Value by Application (2018-2029)
    9.3 South America Gene Therapy For Cancer Market Size by Country
        9.3.1 South America Gene Therapy For Cancer Consumption Value by Country (2018-2029)
        9.3.2 Brazil Gene Therapy For Cancer Market Size and Forecast (2018-2029)
        9.3.3 Argentina Gene Therapy For Cancer Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Gene Therapy For Cancer Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Gene Therapy For Cancer Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Gene Therapy For Cancer Market Size by Country
        10.3.1 Middle East & Africa Gene Therapy For Cancer Consumption Value by Country (2018-2029)
        10.3.2 Turkey Gene Therapy For Cancer Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Gene Therapy For Cancer Market Size and Forecast (2018-2029)
        10.3.4 UAE Gene Therapy For Cancer Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Gene Therapy For Cancer Market Drivers
    11.2 Gene Therapy For Cancer Market Restraints
    11.3 Gene Therapy For Cancer Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Gene Therapy For Cancer Industry Chain
    12.2 Gene Therapy For Cancer Upstream Analysis
    12.3 Gene Therapy For Cancer Midstream Analysis
    12.4 Gene Therapy For Cancer Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Gene Therapy For Cancer Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Gene Therapy For Cancer Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Gene Therapy For Cancer Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Gene Therapy For Cancer Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. GLIEAD Company Information, Head Office, and Major Competitors
    Table 6. GLIEAD Major Business
    Table 7. GLIEAD Gene Therapy For Cancer Product and Solutions
    Table 8. GLIEAD Gene Therapy For Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. GLIEAD Recent Developments and Future Plans
    Table 10. REGENXBIO Company Information, Head Office, and Major Competitors
    Table 11. REGENXBIO Major Business
    Table 12. REGENXBIO Gene Therapy For Cancer Product and Solutions
    Table 13. REGENXBIO Gene Therapy For Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. REGENXBIO Recent Developments and Future Plans
    Table 15. Autolus Company Information, Head Office, and Major Competitors
    Table 16. Autolus Major Business
    Table 17. Autolus Gene Therapy For Cancer Product and Solutions
    Table 18. Autolus Gene Therapy For Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Autolus Recent Developments and Future Plans
    Table 20. American Gene Technologies Company Information, Head Office, and Major Competitors
    Table 21. American Gene Technologies Major Business
    Table 22. American Gene Technologies Gene Therapy For Cancer Product and Solutions
    Table 23. American Gene Technologies Gene Therapy For Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. American Gene Technologies Recent Developments and Future Plans
    Table 25. Arcellx Company Information, Head Office, and Major Competitors
    Table 26. Arcellx Major Business
    Table 27. Arcellx Gene Therapy For Cancer Product and Solutions
    Table 28. Arcellx Gene Therapy For Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Arcellx Recent Developments and Future Plans
    Table 30. AUSTRIANOVA Company Information, Head Office, and Major Competitors
    Table 31. AUSTRIANOVA Major Business
    Table 32. AUSTRIANOVA Gene Therapy For Cancer Product and Solutions
    Table 33. AUSTRIANOVA Gene Therapy For Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. AUSTRIANOVA Recent Developments and Future Plans
    Table 35. Alphavax Company Information, Head Office, and Major Competitors
    Table 36. Alphavax Major Business
    Table 37. Alphavax Gene Therapy For Cancer Product and Solutions
    Table 38. Alphavax Gene Therapy For Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Alphavax Recent Developments and Future Plans
    Table 40. Cellectis Company Information, Head Office, and Major Competitors
    Table 41. Cellectis Major Business
    Table 42. Cellectis Gene Therapy For Cancer Product and Solutions
    Table 43. Cellectis Gene Therapy For Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Cellectis Recent Developments and Future Plans
    Table 45. Chimeron Company Information, Head Office, and Major Competitors
    Table 46. Chimeron Major Business
    Table 47. Chimeron Gene Therapy For Cancer Product and Solutions
    Table 48. Chimeron Gene Therapy For Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. Chimeron Recent Developments and Future Plans
    Table 50. Global Gene Therapy For Cancer Revenue (USD Million) by Players (2018-2023)
    Table 51. Global Gene Therapy For Cancer Revenue Share by Players (2018-2023)
    Table 52. Breakdown of Gene Therapy For Cancer by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 53. Market Position of Players in Gene Therapy For Cancer, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 54. Head Office of Key Gene Therapy For Cancer Players
    Table 55. Gene Therapy For Cancer Market: Company Product Type Footprint
    Table 56. Gene Therapy For Cancer Market: Company Product Application Footprint
    Table 57. Gene Therapy For Cancer New Market Entrants and Barriers to Market Entry
    Table 58. Gene Therapy For Cancer Mergers, Acquisition, Agreements, and Collaborations
    Table 59. Global Gene Therapy For Cancer Consumption Value (USD Million) by Type (2018-2023)
    Table 60. Global Gene Therapy For Cancer Consumption Value Share by Type (2018-2023)
    Table 61. Global Gene Therapy For Cancer Consumption Value Forecast by Type (2024-2029)
    Table 62. Global Gene Therapy For Cancer Consumption Value by Application (2018-2023)
    Table 63. Global Gene Therapy For Cancer Consumption Value Forecast by Application (2024-2029)
    Table 64. North America Gene Therapy For Cancer Consumption Value by Type (2018-2023) & (USD Million)
    Table 65. North America Gene Therapy For Cancer Consumption Value by Type (2024-2029) & (USD Million)
    Table 66. North America Gene Therapy For Cancer Consumption Value by Application (2018-2023) & (USD Million)
    Table 67. North America Gene Therapy For Cancer Consumption Value by Application (2024-2029) & (USD Million)
    Table 68. North America Gene Therapy For Cancer Consumption Value by Country (2018-2023) & (USD Million)
    Table 69. North America Gene Therapy For Cancer Consumption Value by Country (2024-2029) & (USD Million)
    Table 70. Europe Gene Therapy For Cancer Consumption Value by Type (2018-2023) & (USD Million)
    Table 71. Europe Gene Therapy For Cancer Consumption Value by Type (2024-2029) & (USD Million)
    Table 72. Europe Gene Therapy For Cancer Consumption Value by Application (2018-2023) & (USD Million)
    Table 73. Europe Gene Therapy For Cancer Consumption Value by Application (2024-2029) & (USD Million)
    Table 74. Europe Gene Therapy For Cancer Consumption Value by Country (2018-2023) & (USD Million)
    Table 75. Europe Gene Therapy For Cancer Consumption Value by Country (2024-2029) & (USD Million)
    Table 76. Asia-Pacific Gene Therapy For Cancer Consumption Value by Type (2018-2023) & (USD Million)
    Table 77. Asia-Pacific Gene Therapy For Cancer Consumption Value by Type (2024-2029) & (USD Million)
    Table 78. Asia-Pacific Gene Therapy For Cancer Consumption Value by Application (2018-2023) & (USD Million)
    Table 79. Asia-Pacific Gene Therapy For Cancer Consumption Value by Application (2024-2029) & (USD Million)
    Table 80. Asia-Pacific Gene Therapy For Cancer Consumption Value by Region (2018-2023) & (USD Million)
    Table 81. Asia-Pacific Gene Therapy For Cancer Consumption Value by Region (2024-2029) & (USD Million)
    Table 82. South America Gene Therapy For Cancer Consumption Value by Type (2018-2023) & (USD Million)
    Table 83. South America Gene Therapy For Cancer Consumption Value by Type (2024-2029) & (USD Million)
    Table 84. South America Gene Therapy For Cancer Consumption Value by Application (2018-2023) & (USD Million)
    Table 85. South America Gene Therapy For Cancer Consumption Value by Application (2024-2029) & (USD Million)
    Table 86. South America Gene Therapy For Cancer Consumption Value by Country (2018-2023) & (USD Million)
    Table 87. South America Gene Therapy For Cancer Consumption Value by Country (2024-2029) & (USD Million)
    Table 88. Middle East & Africa Gene Therapy For Cancer Consumption Value by Type (2018-2023) & (USD Million)
    Table 89. Middle East & Africa Gene Therapy For Cancer Consumption Value by Type (2024-2029) & (USD Million)
    Table 90. Middle East & Africa Gene Therapy For Cancer Consumption Value by Application (2018-2023) & (USD Million)
    Table 91. Middle East & Africa Gene Therapy For Cancer Consumption Value by Application (2024-2029) & (USD Million)
    Table 92. Middle East & Africa Gene Therapy For Cancer Consumption Value by Country (2018-2023) & (USD Million)
    Table 93. Middle East & Africa Gene Therapy For Cancer Consumption Value by Country (2024-2029) & (USD Million)
    Table 94. Gene Therapy For Cancer Raw Material
    Table 95. Key Suppliers of Gene Therapy For Cancer Raw Materials
List of Figures
    Figure 1. Gene Therapy For Cancer Picture
    Figure 2. Global Gene Therapy For Cancer Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Gene Therapy For Cancer Consumption Value Market Share by Type in 2022
    Figure 4. Rb Gene
    Figure 5. P53 Gene
    Figure 6. APC Gene
    Figure 7. NF1 Gene
    Figure 8. Others
    Figure 9. Global Gene Therapy For Cancer Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 10. Gene Therapy For Cancer Consumption Value Market Share by Application in 2022
    Figure 11. Cancer Treatment Picture
    Figure 12. Tissue Repair Picture
    Figure 13. Others Picture
    Figure 14. Global Gene Therapy For Cancer Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 15. Global Gene Therapy For Cancer Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 16. Global Market Gene Therapy For Cancer Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 17. Global Gene Therapy For Cancer Consumption Value Market Share by Region (2018-2029)
    Figure 18. Global Gene Therapy For Cancer Consumption Value Market Share by Region in 2022
    Figure 19. North America Gene Therapy For Cancer Consumption Value (2018-2029) & (USD Million)
    Figure 20. Europe Gene Therapy For Cancer Consumption Value (2018-2029) & (USD Million)
    Figure 21. Asia-Pacific Gene Therapy For Cancer Consumption Value (2018-2029) & (USD Million)
    Figure 22. South America Gene Therapy For Cancer Consumption Value (2018-2029) & (USD Million)
    Figure 23. Middle East and Africa Gene Therapy For Cancer Consumption Value (2018-2029) & (USD Million)
    Figure 24. Global Gene Therapy For Cancer Revenue Share by Players in 2022
    Figure 25. Gene Therapy For Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 26. Global Top 3 Players Gene Therapy For Cancer Market Share in 2022
    Figure 27. Global Top 6 Players Gene Therapy For Cancer Market Share in 2022
    Figure 28. Global Gene Therapy For Cancer Consumption Value Share by Type (2018-2023)
    Figure 29. Global Gene Therapy For Cancer Market Share Forecast by Type (2024-2029)
    Figure 30. Global Gene Therapy For Cancer Consumption Value Share by Application (2018-2023)
    Figure 31. Global Gene Therapy For Cancer Market Share Forecast by Application (2024-2029)
    Figure 32. North America Gene Therapy For Cancer Consumption Value Market Share by Type (2018-2029)
    Figure 33. North America Gene Therapy For Cancer Consumption Value Market Share by Application (2018-2029)
    Figure 34. North America Gene Therapy For Cancer Consumption Value Market Share by Country (2018-2029)
    Figure 35. United States Gene Therapy For Cancer Consumption Value (2018-2029) & (USD Million)
    Figure 36. Canada Gene Therapy For Cancer Consumption Value (2018-2029) & (USD Million)
    Figure 37. Mexico Gene Therapy For Cancer Consumption Value (2018-2029) & (USD Million)
    Figure 38. Europe Gene Therapy For Cancer Consumption Value Market Share by Type (2018-2029)
    Figure 39. Europe Gene Therapy For Cancer Consumption Value Market Share by Application (2018-2029)
    Figure 40. Europe Gene Therapy For Cancer Consumption Value Market Share by Country (2018-2029)
    Figure 41. Germany Gene Therapy For Cancer Consumption Value (2018-2029) & (USD Million)
    Figure 42. France Gene Therapy For Cancer Consumption Value (2018-2029) & (USD Million)
    Figure 43. United Kingdom Gene Therapy For Cancer Consumption Value (2018-2029) & (USD Million)
    Figure 44. Russia Gene Therapy For Cancer Consumption Value (2018-2029) & (USD Million)
    Figure 45. Italy Gene Therapy For Cancer Consumption Value (2018-2029) & (USD Million)
    Figure 46. Asia-Pacific Gene Therapy For Cancer Consumption Value Market Share by Type (2018-2029)
    Figure 47. Asia-Pacific Gene Therapy For Cancer Consumption Value Market Share by Application (2018-2029)
    Figure 48. Asia-Pacific Gene Therapy For Cancer Consumption Value Market Share by Region (2018-2029)
    Figure 49. China Gene Therapy For Cancer Consumption Value (2018-2029) & (USD Million)
    Figure 50. Japan Gene Therapy For Cancer Consumption Value (2018-2029) & (USD Million)
    Figure 51. South Korea Gene Therapy For Cancer Consumption Value (2018-2029) & (USD Million)
    Figure 52. India Gene Therapy For Cancer Consumption Value (2018-2029) & (USD Million)
    Figure 53. Southeast Asia Gene Therapy For Cancer Consumption Value (2018-2029) & (USD Million)
    Figure 54. Australia Gene Therapy For Cancer Consumption Value (2018-2029) & (USD Million)
    Figure 55. South America Gene Therapy For Cancer Consumption Value Market Share by Type (2018-2029)
    Figure 56. South America Gene Therapy For Cancer Consumption Value Market Share by Application (2018-2029)
    Figure 57. South America Gene Therapy For Cancer Consumption Value Market Share by Country (2018-2029)
    Figure 58. Brazil Gene Therapy For Cancer Consumption Value (2018-2029) & (USD Million)
    Figure 59. Argentina Gene Therapy For Cancer Consumption Value (2018-2029) & (USD Million)
    Figure 60. Middle East and Africa Gene Therapy For Cancer Consumption Value Market Share by Type (2018-2029)
    Figure 61. Middle East and Africa Gene Therapy For Cancer Consumption Value Market Share by Application (2018-2029)
    Figure 62. Middle East and Africa Gene Therapy For Cancer Consumption Value Market Share by Country (2018-2029)
    Figure 63. Turkey Gene Therapy For Cancer Consumption Value (2018-2029) & (USD Million)
    Figure 64. Saudi Arabia Gene Therapy For Cancer Consumption Value (2018-2029) & (USD Million)
    Figure 65. UAE Gene Therapy For Cancer Consumption Value (2018-2029) & (USD Million)
    Figure 66. Gene Therapy For Cancer Market Drivers
    Figure 67. Gene Therapy For Cancer Market Restraints
    Figure 68. Gene Therapy For Cancer Market Trends
    Figure 69. Porters Five Forces Analysis
    Figure 70. Manufacturing Cost Structure Analysis of Gene Therapy For Cancer in 2022
    Figure 71. Manufacturing Process Analysis of Gene Therapy For Cancer
    Figure 72. Gene Therapy For Cancer Industrial Chain
    Figure 73. Methodology
    Figure 74. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

GLIEAD
REGENXBIO
Autolus
American Gene Technologies
Arcellx
AUSTRIANOVA
Alphavax
Cellectis
Chimeron

Related Reports

Global Gene Therapy For Cancer Supply, Demand and Key Producers, 2023-2029

Global Gene Therapy For Cancer Supply, Demand and Key Producers, 2023-2029

date 21 Apr 2023

date Medical Care

The global Gene Therapy For Cancer market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Gene Therapy For Cancer Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Gene Therapy For Cancer Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Gene Therapy For Cancer market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Gene Therapy For Cancer

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>